An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes - PubMed (original) (raw)
An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes
D Liebowitz et al. Mol Cell Biol. 1987 Jul.
Abstract
The Epstein-Barr virus (EBV) latent infection membrane protein (LMP) is likely to be an important mediator of EBV-induced cell proliferation, since it is one of the few proteins encoded by the virus in latent infection and since production of this protein in Rat-1 cells results in their conversion to a fully transformed phenotype. LMP was previously noted to localize to patches at the cell periphery. In this paper we examine the basis of LMP patching in EBV-infected, transformed lymphocytes. Our data indicate that LMP is associated with the cytoskeletal protein vimentin. Although LMP is fully soluble in isotonic Triton X-100 buffer, only 50% of it is extracted from cells in this solution. The rest remains bound to the cytoskeleton. LMP undergoes phosphorylation, and phosphorylated LMP is preferentially associated with the cytoskeleton. As judged by both immunofluorescence and immunoelectron microscopy, the vimentin network in EBV-transformed lymphocytes or EBV-infected Burkitt tumor lymphocytes is abnormal. Vimentin and LMP often colocalize in a single patch near the plasma membrane. In response to Colcemid treatment of EBV-infected cells, vimentin reorganizes into perinuclear rings, as it does in uninfected cells. LMP is associated with these perinuclear rings. Vimentin (or a vimentin-associated protein) may be a transducer of an LMP transmembrane effect in lymphoproliferation.
Similar articles
- Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.
Wang D, Liebowitz D, Wang F, Gregory C, Rickinson A, Larson R, Springer T, Kieff E. Wang D, et al. J Virol. 1988 Nov;62(11):4173-84. doi: 10.1128/JVI.62.11.4173-4184.1988. J Virol. 1988. PMID: 2845129 Free PMC article. - Epstein-Barr virus latent membrane protein: induction of B-cell activation antigens and membrane patch formation does not require vimentin.
Liebowitz D, Kieff E. Liebowitz D, et al. J Virol. 1989 Sep;63(9):4051-4. doi: 10.1128/JVI.63.9.4051-4054.1989. J Virol. 1989. PMID: 2668563 Free PMC article. - The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts.
Wang D, Liebowitz D, Kieff E. Wang D, et al. J Virol. 1988 Jul;62(7):2337-46. doi: 10.1128/JVI.62.7.2337-2346.1988. J Virol. 1988. PMID: 2836616 Free PMC article. - Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
Kis LL, Takahara M, Nagy N, Klein G, Klein E. Kis LL, et al. Immunol Lett. 2006 Apr 15;104(1-2):83-8. doi: 10.1016/j.imlet.2005.11.003. Epub 2005 Dec 1. Immunol Lett. 2006. PMID: 16386314 Review. - T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB, Murray RJ, Brooks J, Griffin H, Moss DJ, Masucci MG. Rickinson AB, et al. Cancer Surv. 1992;13:53-80. Cancer Surv. 1992. PMID: 1330300 Review.
Cited by
- New Look of EBV LMP1 Signaling Landscape.
Wang L, Ning S. Wang L, et al. Cancers (Basel). 2021 Oct 29;13(21):5451. doi: 10.3390/cancers13215451. Cancers (Basel). 2021. PMID: 34771613 Free PMC article. Review. - The Epstein-Barr virus LMP1 interactome: biological implications and therapeutic targets.
Cheerathodi MR, Meckes DG Jr. Cheerathodi MR, et al. Future Virol. 2018 Dec;13(12):863-887. doi: 10.2217/fvl-2018-0120. Epub 2018 Dec 3. Future Virol. 2018. PMID: 34079586 Free PMC article. - Artemisinins target the intermediate filament protein vimentin for human cytomegalovirus inhibition.
Roy S, Kapoor A, Zhu F, Mukhopadhyay R, Ghosh AK, Lee H, Mazzone J, Posner GH, Arav-Boger R. Roy S, et al. J Biol Chem. 2020 Oct 30;295(44):15013-15028. doi: 10.1074/jbc.RA120.014116. Epub 2020 Aug 27. J Biol Chem. 2020. PMID: 32855235 Free PMC article. - Human Enterovirus Group B Viruses Rely on Vimentin Dynamics for Efficient Processing of Viral Nonstructural Proteins.
Turkki P, Laajala M, Flodström-Tullberg M, Marjomäki V. Turkki P, et al. J Virol. 2020 Jan 6;94(2):e01393-19. doi: 10.1128/JVI.01393-19. Print 2020 Jan 6. J Virol. 2020. PMID: 31619557 Free PMC article. - Infectious Mononucleosis Triggers Generation of IgG Auto-Antibodies against Native Myelin Oligodendrocyte Glycoprotein.
Kakalacheva K, Regenass S, Wiesmayr S, Azzi T, Berger C, Dale RC, Brilot F, Münz C, Rostasy K, Nadal D, Lünemann JD. Kakalacheva K, et al. Viruses. 2016 Feb 12;8(2):51. doi: 10.3390/v8020051. Viruses. 2016. PMID: 26907324 Free PMC article.
References
- Exp Cell Res. 1979 Oct 1;123(1):25-46 - PubMed
- J Immunol. 1979 Jan;122(1):97-107 - PubMed
- J Immunol. 1982 Mar;128(3):1198-204 - PubMed
- J Virol. 1983 Jun;46(3):800-7 - PubMed
- Proc Natl Acad Sci U S A. 1983 Jun;80(12):3548-52 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials